查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413094

發作性睡病治療藥物市場：按類型、治療藥物類型 - 全球預測 2024-2030

Narcolepsy Drugs Market by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Therapeutics Type (Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, Sodium Oxybate) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年發作性睡病治療藥物市場規模為30.5億美元，2024年預計將達32.8億美元，2030年將達48.3億美元，複合年成長率為6.77%。

發作性睡病藥物的全球市場

主要市場統計
基準年[2023] 30.5億美元
預測年份 [2024] 32.8億美元
預測年份 [2030] 48.3億美元
複合年成長率（%） 6.77%
發作性睡病治療藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估發作性睡病藥物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對發作性睡病治療藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-發作性睡病治療藥物市場的市場規模和預測是多少？

2-在發作性睡病治療藥物市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-發作性睡病藥物市場的技術趨勢和法律規範是什麼？

4-發作性睡病治療藥物市場主要供應商的市場佔有率是多少？

5-進入發作性睡病藥物市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 發作性睡病患病率增加
      • 提高消費者對發作性睡病藥物益處的認知
      • 睡眠相關疾病的醫療費用增加
    • 抑制因素
      • 發作性睡病藥物的副作用
    • 機會
      • 政府努力開發治療發作性睡病的藥物
      • 開發新藥的持續研究和開發活動
    • 任務
      • 對新興經濟體的滲透率下降
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章發作性睡病治療藥物市場：依類型

  • 發作性睡病伴隨猝倒
  • 不伴猝倒的發作性睡病
  • 次發性發作性睡病

第7章發作性睡病治療藥物市場（依治療藥物類型）

  • 中樞神經系統興奮劑
  • 選擇性血清素再回收抑制劑
  • 氧化鈉
  • 三環抗憂鬱藥物

第8章美洲發作性睡病藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區發作性睡病治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的發作性睡病治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第12章競爭產品組合

  • 主要公司簡介
    • Apotex Inc.
    • Aurobindo Pharma Ltd.
    • Avadel Pharmaceuticals Plc
    • Axsome Therapeutics Inc.
    • Cadila Pharmaceuticals Ltd.
    • Don Valley Pharmaceuticals
    • Graymark Healthcare Inc.
    • Jabs Biotech Pvt. Ltd.
    • Jazz Pharmaceuticals PLC
    • Luckys Pharma Pvt. Ltd.
    • Midas Pharma GmbH
    • Orbion Pharmaceuticals Pvt. Ltd.
    • Shionogi and Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • XWPharma Ltd.
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-62667ADF9646

[195 Pages Report] The Narcolepsy Drugs Market size was estimated at USD 3.05 billion in 2023 and expected to reach USD 3.28 billion in 2024, at a CAGR 6.77% to reach USD 4.83 billion by 2030.

Global Narcolepsy Drugs Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.05 billion
Estimated Year [2024] USD 3.28 billion
Forecast Year [2030] USD 4.83 billion
CAGR (%) 6.77%
Narcolepsy Drugs Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Narcolepsy Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Narcolepsy Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Narcolepsy Drugs Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Aurobindo Pharma Ltd., Avadel Pharmaceuticals Plc, Axsome Therapeutics Inc., Cadila Pharmaceuticals Ltd., Don Valley Pharmaceuticals, Graymark Healthcare Inc., Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals PLC, Luckys Pharma Pvt. Ltd., Midas Pharma GmbH, Orbion Pharmaceuticals Pvt. Ltd., Shionogi and Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and XWPharma Ltd..

Market Segmentation & Coverage

This research report categorizes the Narcolepsy Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Narcolepsy with Cataplexy
    • Narcolepsy without Cataplexy
    • Secondary Narcolepsy
  • Therapeutics Type
    • Central Nervous System Stimulants
    • Selective Serotonin Reuptake Inhibitor
    • Sodium Oxybate
    • Tricyclic Antidepressants
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Narcolepsy Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Narcolepsy Drugs Market?

3. What are the technology trends and regulatory frameworks in the Narcolepsy Drugs Market?

4. What is the market share of the leading vendors in the Narcolepsy Drugs Market?

5. Which modes and strategic moves are suitable for entering the Narcolepsy Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Narcolepsy Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of narcolepsy disorder
      • 5.1.1.2. Growing consumer awareness towards benefits of narcolepsy drugs
      • 5.1.1.3. Rising healthcare spending for sleep related disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects of narcolepsy drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Governmental initiatives for narcolepsy drug development
      • 5.1.3.2. Ongoing research and development activities for novel drug development
    • 5.1.4. Challenges
      • 5.1.4.1. Less penetration across developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Narcolepsy Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Narcolepsy with Cataplexy
  • 6.3. Narcolepsy without Cataplexy
  • 6.4. Secondary Narcolepsy

7. Narcolepsy Drugs Market, by Therapeutics Type

  • 7.1. Introduction
  • 7.2. Central Nervous System Stimulants
  • 7.3. Selective Serotonin Reuptake Inhibitor
  • 7.4. Sodium Oxybate
  • 7.5. Tricyclic Antidepressants

8. Americas Narcolepsy Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Narcolepsy Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Narcolepsy Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Apotex Inc.
    • 12.1.2. Aurobindo Pharma Ltd.
    • 12.1.3. Avadel Pharmaceuticals Plc
    • 12.1.4. Axsome Therapeutics Inc.
    • 12.1.5. Cadila Pharmaceuticals Ltd.
    • 12.1.6. Don Valley Pharmaceuticals
    • 12.1.7. Graymark Healthcare Inc.
    • 12.1.8. Jabs Biotech Pvt. Ltd.
    • 12.1.9. Jazz Pharmaceuticals PLC
    • 12.1.10. Luckys Pharma Pvt. Ltd.
    • 12.1.11. Midas Pharma GmbH
    • 12.1.12. Orbion Pharmaceuticals Pvt. Ltd.
    • 12.1.13. Shionogi and Co. Ltd.
    • 12.1.14. Takeda Pharmaceutical Co. Ltd.
    • 12.1.15. Teva Pharmaceutical Industries Ltd.
    • 12.1.16. XWPharma Ltd.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NARCOLEPSY DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. NARCOLEPSY DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NARCOLEPSY DRUGS MARKET DYNAMICS
  • FIGURE 7. NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2023 VS 2030 (%)
  • FIGURE 10. NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NARCOLEPSY DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. NARCOLEPSY DRUGS MARKET SIZE, BY NARCOLEPSY WITH CATAPLEXY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NARCOLEPSY DRUGS MARKET SIZE, BY NARCOLEPSY WITHOUT CATAPLEXY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NARCOLEPSY DRUGS MARKET SIZE, BY SECONDARY NARCOLEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. NARCOLEPSY DRUGS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NARCOLEPSY DRUGS MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NARCOLEPSY DRUGS MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NARCOLEPSY DRUGS MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY THERAPEUTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. NARCOLEPSY DRUGS MARKET LICENSE & PRICING